IMI2_ROADMAP Profile Banner
IMI2 ROADMAP Profile
IMI2 ROADMAP

@IMI2_ROADMAP

Followers
1K
Following
2K
Media
400
Statuses
1K

Foundation for an integrated #data environment and framework for #RealWorldEvidence #RWE in #Alzheimer’s disease. Visit our newsletter: https://t.co/KknI3uWjVK

This work has received support from the EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking ROADMAP grant n°116020.
Joined January 2017
Don't wanna be here? Send us removal request.
@IMI2_ROADMAP
IMI2 ROADMAP
7 years
Huge thank you to each @IMI2_ROADMAP partner! Excellent two years, demonstrating the ability of academic, industry, advocacy and regulatory partners to work together on a highly complex, widely distributed, and tightly time-constrained project. #28AEC #ROADMAP Phase 1 complete
0
9
15
@IHI_PROMINENT
IHI Prominent
2 years
Exciting news for #neurodegenerative🧠disease research! Today, @IHI_PROMINENT project partners announced the launch of a collaborative pan-European 🇪🇺 initiative funded through @IHIEurope #precisionmedicine #neurodegenerativedisease #CarryTheTorch ⤵️ https://t.co/fsNgKcX9iD
0
3
10
@ADIS_JPND
ADIS
3 years
Have a read of the latest @AlzheimerEurope newsletter, covering updates on 🇪🇺 research projects on #neurodegeneration🧠such as @AIMind_eu @IMI_AMYPAD @EBRAINS_eu @IMI_EPAD @imi_epnd @RADARAD7 @IMI2_ROADMAP & @IMI2_NEURONET ⤵️
@AlzheimerEurope
Alzheimer Europe
3 years
Pleased to launch our November newsletter, including info on: Upcoming Slovenian National Dementia Strategy until 2030 On-demand content for #32AEC available until 31 January 2023 Important clinical trial results presented at #CTAD2022 And much more...! https://t.co/fk8EI8Mpe7
0
8
13
@AlzheimerEurope
Alzheimer Europe
3 years
The @IHIEurope @IMI2_ROADMAP consortium published an article on expert perspectives on health economic modelling for #Alzheimer’s disease Congratulations to Filipa Landeiro @HERC_Oxford et al. https://t.co/SSDJnP17DU
Tweet card summary image
alzheimer-europe.org
On 26 October, partners of the ROADMAP project published opinions on how future economic models for Alzheimer’s disease (AD) might be structured, vali
0
4
7
@IMI2_NEURONET
Neuronet
3 years
Last but not least a special thanks to all members of the communication expert community who contributed to our on dissemination and outreach activities about which we also sent a report to @IHIEurope
0
5
14
@IMI2_NEURONET
Neuronet
3 years
Since its inception, @IMI2_NEURONET has worked to create a platform that boosts synergy and collaboration across the @IHIEurope neurodegeneration portfolio. You can see this work on the NEURONET Knowledge Base & Asset Map, which can be accessed here: https://t.co/yOwC8NAo7l
0
7
13
@HeinsPascale
Pascale Heins
3 years
To all the EARLY CAREER RESEARCHERS IN DEMENTIA: share via this survey ( https://t.co/V61W8WtrSv) how organisations like @InterdemEurope or @ISTAART could support you in your work. It takes only 15 minutes! Results will be discussed during #32AEC @AlzheimerEurope @DTdementia
0
20
21
@IMI2_NEURONET
Neuronet
3 years
Last week we had the pleasure to hold our final meeting along with members from our Scientific Coordination Board. This was a great opportunity to recap on our many activities & innovations over the past 3 years but also to do an assessment @IHIEurope https://t.co/beg2SPa1Vc
Tweet card summary image
imi-neuronet.org
On 1 July, representatives of Neuronet's partner organisations and members of its Scientific Coordination Board (SCB) came together in Barcelona (Spain) to compile and evaluate the achievements of Neu
1
5
5
@IMI2_NEURONET
Neuronet
3 years
Are you interested in the latest developments in #neurodegeneration research? Check out our Knowledge Base with an up-to-date overview of @IHIEurope's public #neurodegeneration project deliverables (447): https://t.co/orQaA3WdXL
0
9
14
@AlzheimerEurope
Alzheimer Europe
3 years
The #AEAntiStigmaAward will recognise an outstanding European initiative working to combat #stigma around dementia. Working in that area or know someone who is (open to individuals or organisations) ? Then find out more: https://t.co/rOsjkobZIJ Deadline is 1 September 2022!
1
9
11
@IMI2_NEURONET
Neuronet
3 years
.@IMI2_NEURONET project coordinator Carlos Díaz @SynapseManagers is highlighting the excellent collaboration with @NICEComms in @IHIEurope research projects & underlines great outputs such as our HTA/regulatory decision tool https://t.co/vWNeXtVBKZ
0
6
11
@SynapseManagers
SYNAPSE R&D Managers
3 years
The Knowledge Base provides a summary view of the @IHIEurope neurodegenerative portfolio, including main assets from projects, their publications, deliverables, but also key utilities such as the Regulatory and HTA Engagement Decision Tool and the Asset Map
0
10
9
@IMI2_NEURONET
Neuronet
3 years
It’s a wrap! Today, we held the last @IMI2_NEURONET meeting reflecting on the support and coordination we provided to the @IHIEurope #neurodegeneration portfolio. Wishing all attendees safe travels home! https://t.co/BStxwYBc64
0
9
18
@IMI2_NEURONET
Neuronet
3 years
Welcome to the members of the @IMI2_Neuronet Scientific Coordination Board formed by leaders of @IHIEurope neurodegeneration projects & chaired by Carlos Dìaz @SynapseManagers. Find out more: https://t.co/FUCmHwY0IH
0
5
12
@IMI2_NEURONET
Neuronet
3 years
Carlos Díaz @SynapseManagers underlines what the public-private partnership between the European Union & the European pharmaceutical industry @IHIEurope is delivering in neurodegeneration research. Check out our Knowledge Base: https://t.co/mdh6mSazZk #IMICarryTheTorch
0
4
8
@IMI2_NEURONET
Neuronet
3 years
Carlos Diaz @SynapseManagers highlights the asset map @IMI2_NEURONET, depicting the outputs of @IHIEurope neurodegeneration projects: 🖥️ data platforms & tools 📰 guidelines for clinical & laboratory research 👩‍⚕️cohorts, biosamples & data Check it out here: https://t.co/vWNeXtVBKZ
0
4
7
@SynapseManagers
SYNAPSE R&D Managers
3 years
Carlos Díaz is going through @IMI2_NEURONET's key outputs during the morning session. Last year, the project publicly launched one of its key tools, the Knowledge Base, developed by SYNAPSE 👉 https://t.co/yCTMtq3QkP #neurodegeneration #HealthierFuture #IMICarryTheTorch
0
4
7
@SynapseManagers
SYNAPSE R&D Managers
3 years
📢 All set to start the Final Consortium Meeting of @IMI2_NEURONET in Barcelona Consortium members are gathering today to discuss NEURONET’s activities, outputs and successes over the past three years #neurodegeneration #HealthierFuture #IMICarryTheTorch
0
3
8
@IMI2_NEURONET
Neuronet
3 years
Where are we today? @IMI2_NEURONET's Consortium & members from our Scientific Coordination Board are meeting in #Barcelona to reflect on our activities and innovations over the past 3 years. Exciting times to be involved in #neurodegeneration research #HealthierFuture
1
5
10
@IHIEurope
Innovative Health Initiative
3 years
Great to see the outputs of IMI project @IMI2_ROADMAP being used like this!
@AngeBradshaw_AE
Angela Bradshaw
3 years
What matters most to people with #dementia and their caregivers? Great presentation by @Hopper__Louise on the co-design of a national dementia registry for 🇮🇪, referencing the @IMI2_ROADMAP systematic review by @MJSmith0611, @ChrisBintener and others #ADI2022
0
4
11